TITLE

A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension

AUTHOR(S)
Narayanaswamy, Arun; Neog, Aditya; Baskaran, M.; George, Ronnie; Lingam, Vijaya; Desai, Chetan; Rajadhyaksha, Viraj
PUB. DATE
March 2007
SOURCE
Indian Journal of Ophthalmology;Mar2007, Vol. 55 Issue 2, p127
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
24286237

 

Related Articles

  • Punctal plug delivery system shows good safety, efficacy.  // Primary Care Optometry News;Dec2012, Vol. 17 Issue 12, p7 

    The article highlights findings of a study which evaluated the safety and efficacy of a punctal plug delivery system with latanoprost when used in subjects with ocular hypertension or open-angle glaucoma.

  • Xalatan.  // Royal Society of Medicine: Medicines;2002, p571 

    This article provides information on Xalatan, a proprietary, prescription-only preparation of the prostaglandin analogue latanoprost. It can be used as a glaucoma treatment in open-angle glaucoma and ocular hypertension. It is available as eye-drops.

  • Days of IOP control help determine drug effectiveness. Zimmerman, Thom J. // Ophthalmology Times;1/15/2007, Vol. 32 Issue 2, p43 

    The article evaluates the drug latanoprost (Xalatan), prescribed for patients undergoing treatment for primary open-angle glaucoma, which is manufactured by Pfizer Inc.

  • OHTS Guide: The Clinical Findings.  // Review of Optometry;12/15/2002, Vol. 139 Issue 12, p44 

    Examines the efficacy of he Ocular Hypertension Treatment Study (OHTS) in assisting clinicians on treatment decisions for ocular hypertension. Functions of the OHTS and evaluating the safety and efficacy of topical ocular hypotensive medication; Aims in preventing the development of primary...

  • Preservative-Free Latanoprost Eye Drops in Patients with Primary Open-Angle Glaucoma/Ocular Hypertension. Sanford, Mark // Clinical Drug Investigation;Jul2014, Vol. 34 Issue 7, p521 

    Latanoprost is an ester prodrug prostaglandin F analogue that is a selective agonist of endogenous prostanoid FP receptors and that reduces intraocular pressure (IOP) by increasing the uveoscleral outflow of aqueous humour. Preservative-free (PF) latanoprost [Monoprost] is a new formulation of...

  • HLA-DR Expression in Conjunctival Cells After Latanoprost. Guglielminetti, Elena; Barabino, Stefano; Monaco, Marina; Mantero, Stefano; Rolando, Maurizio // Journal of Ocular Pharmacology & Therapeutics;Feb2002, Vol. 18 Issue 1, p1 

    The purpose of this randomized, controlled, masked study was to evaluate the effects of latanoprost 0.005% (Xalatan[sup �], Pharmacia and Upjohn, Milan, Italy) on the ocular surface in patients with ocular hypertension or primary open-angle glaucoma. The study group included 14 patients who...

  • Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy. Stewart, W. C.; Stewart, J. A.; Day, D. G.; Sharpe, E. D.; Jenkins, J. N. // Eye;Oct2004, Vol. 18 Issue 10, p990 

    AIMS:To evaluate the efficacy and safety of latanoprost/timolol maleate fixed combination (LTFC) given once daily vs the concomitant therapy of brimonidine twice daily and latanoprost once daily in primary open-angle glaucoma or ocular hypertensive subjects. METHODS:A prospective, double-masked,...

  • Phase 2 trials demonstrate efficacy of punctal plug in lowering IOP.  // Primary Care Optometry News;Dec2012, Vol. 17 Issue 12, p18 

    The article highlights two multi center phase 2 clinical trials which demonstrated the safety and efficacy of Latanoprost Punctal Plug Delivery System from QLT in patients with ocular hypertension and open-angle glaucoma.

  • The Use of Latanoprost 0.005% Once Daily and its Effect on Intraocular Pressure as Primary or Adjunctive Therapy. Smith, Shannon L.; Stewart, William C.; Sine, Cheryl S.; Pruitt, Caroline A. // Journal of Ocular Pharmacology & Therapeutics;Feb99, Vol. 15 Issue 1, p29 

    Presents a study which evaluated differences in efficacy and safety of latanoprost as monotherapy compared to adjunctive therapy in primary open-angle glaucoma. Materials and methods; Results; Discussion.

  • How OHTS Will Impact Patient Care. Netland, Peter // Review of Ophthalmology;Nov2002, Vol. 9 Issue 11, p34 

    Examines the implications of the Ocular Hypertension Treatment Study for patient care in the U.S. Prevention of the onset of primary open angle glaucoma; Safety and efficacy of ocular hypotensive medication; Procedures for treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics